Skip to main content

UBS Group AG

Position in RCUS — Arcus Biosciences, Inc.

CIK 1610520 ZURICH, V8

Position in RCUS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$11,377,995
+$5,138,685 QoQ
Shares Held
369,056
+27.8% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 230 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RCUS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. RCUS ranks #108 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RCUS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,377,995 369,056
2026-03-31 $6,239,310 288,857
2025-12-31 $9,800,301 411,259
2025-09-30 $2,276,694 167,404
2025-06-30 $755,400 92,801
2025-03-31 $1,093,873 139,347
2024-12-31 $1,951,542 131,064
2024-09-30 $1,313,349 85,896
2024-06-30 $1,143,970 75,113
2024-03-31 $3,940,803 208,729
2023-12-31 $3,103,444 162,484
2023-09-30 $1,032,788 57,537
2023-06-30 $2,016,660 99,294
2023-03-31 $1,799,503 98,657
2022-12-31 $1,235,588 59,748
2022-09-30 $1,038,447 39,696
2022-06-30 $1,978,496 78,078
2022-03-31 $6,118,821 193,879
2021-12-31 $235,129 5,810
2021-09-30 $730,735 20,956
2021-06-30 $193,922 7,062
2021-03-31 $1,275,225 45,414
2020-12-31 $9,631 371
2020-06-30 $92,353 3,733
2020-03-31 $292,271 21,057